All Stories

  1. APA and RBPs
  2. Alternative Polyadenylation: Another Foe in Cancer
  3. Mechanisms of mRNA polyadenylation
  4. EGF induced alternative polyadenylation in triple negative breast cancers
  5. stress-responsive miRNAs in transgenic plants
  6. ALCAM is indirectly modulated by miR-125b in MCF7 cells
  7. ARID3B expression in primary breast cancers and breast cancer-derived cell lines
  8. Alternative Polyadenylation and Its Impact on Cellular Processes
  9. Noncoding RNAs and cancer
  10. USP32 (ubiquitin specific peptidase 32)
  11. Introduction to MicroRNAs
  12. MIR106B (microRNA 106b)
  13. Estrogen and APA
  14. A sandwich hybridization base miRNA detection chip
  15. Matrix metalloprotease 16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells
  16. miR-125b Targets ARID3B in Breast Cancer Cells
  17. MIR10B (microRNA 10b)
  18. MIR125B1 (microRNA 125b-1)
  19. MIR125B2 (microRNA 125b-2)
  20. MIR125A (microRNA 125a)
  21. MIR222 (microRNA 222)
  22. MIR221 (microRNA 221)
  23. Kidney: Nephroblastoma (Wilms tumor)
  24. MIRN21 (microRNA 21)
  25. TBX2 (T-box 2)
  26. TRIM37 (tripartite motif-containing 37)
  27. CHFR (checkpoint with fork-head associated and ring finger)
  28. PLK1 (polo-like kinase 1 (Drosophila))
  29. Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?
  30. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers
  31. 681 Characterization of a ubiquitin specific protease in the 17q23 amplicon
  32. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy
  33. miRNAs and cancer: New research developments and potential clinical applications
  34. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions
  35. A parylene‐based dual channel micro‐electrophoresis system for rapid mutation detection via heteroduplex analysis
  36. MicroRNAs in development and disease
  37. Molecular and Genetic Events in Neoplastic Transformation
  38. CHFR-associated early G2/M checkpoint defects in breast cancer cells